Neostigmine Methylsulfate 25021-0610-10
- Manufacturer
- Sagent Pharmaceuticals
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- January 15, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA210652
Need to source Neostigmine Methylsulfate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Neostigmine Methylsulfate | .5 mg/mL |
Drug Class
Cholinesterase Inhibitor [EPC]Cholinesterase Inhibitors [MoA]
Selected Package
25021-0610-10Selected10 VIAL in 1 CARTON (25021-610-10) / 10 mL in 1 VIAL